Mitochondrial dysfunction in CA1 hippocampal neurons of the UBE3A deficient mouse model for Angelman syndrome

Neuroscience Letters
Hailing SuVirginia E Kimonis


Angelman syndrome (AS) is a severe neurological disorder caused by a deficiency of ubiquitin protein ligase E3A (UBE3A), but the pathophysiology of the disease remains unknown. We now report that in the brains of AS mice in which the maternal UBE3A allele is mutated (m-) and the paternal allele is potentially inactivated by imprinting (p+) (UBE3A m-\p+), the mitochondria are abnormal and exhibit a partial oxidative phosphorylation (OXPHOS) defect. Electron microscopy of the hippocampal region of the UBE3A m-\p+ mice (n=6) reveals small, dense mitochondria with altered cristae, relative to wild-type littermates (n=6) and reduced synaptic vesicle density. The specific activity of OXPHOS complex III is reduced in whole brain mitochondria in UBE3A m-\p+ (n=5) mice versus wild-type littermates (n=5). Therefore, mitochondrial dysfunction may contribute to the pathophysiology of Angelman syndrome.


Jul 1, 1990·Journal of Child Neurology·O Eeg-OlofssonM M Al-Essa
Jan 1, 1996·Annual Review of Genetics·M Hochstrasser
Apr 18, 1998·Proceedings of the National Academy of Sciences of the United States of America·A Ciechanover, A L Schwartz
Jul 27, 2004·Current Opinion in Pediatrics·Yong-Hui Jiang, Arthur L Beaudet
Jun 1, 2006·The Journal of Cell Biology·Mafalda Escobar-HenriquesThomas Langer
Jun 20, 2006·Molecular and Cellular Biology·Skirmantas KriaucionisAdrian Bird
Jan 18, 2007·Proceedings of the National Academy of Sciences of the United States of America·Robert A CrozierMark F Bear
Jul 4, 2007·The Journal of Cell Biology·Mariusz KarbowskiRichard J Youle
Nov 6, 2007·Seminars in Pediatric Neurology·Kerry Baldwin Jedele
Feb 22, 2008·Molecular Biology of the Cell·Nobuhiro Nakamura, Shigehisa Hirose
Apr 17, 2008·Human Molecular Genetics·Detlef H HeckLawrence T Reiter
May 12, 2009·Nature Neuroscience·Koji YashiroBenjamin D Philpot


Jan 26, 2011·Molecular Psychiatry·Daniel A Rossignol, Richard E Frye
Apr 2, 2013·The Journal of Clinical Investigation·Douglas C Wallace
Feb 21, 2013·PLoS Biology·Cong CaoJohn Marshall
Dec 4, 2009·Cold Spring Harbor Symposia on Quantitative Biology·Douglas C Wallace
May 17, 2015·FEBS Letters·Mateusz Cyryl Ambrozkiewicz, Hiroshi Kawabe
Jan 14, 2016·Wiener medizinische Wochenschrift·Wen-Hann Tan, Lynne M Bird
Apr 13, 2012·Pediatrics International : Official Journal of the Japan Pediatric Society·Valeria VastaSi Houn Hahn
Apr 28, 2012·Biochimica Et Biophysica Acta·Moyra SmithDouglas C Wallace
Jul 16, 2014·Frontiers in Pediatrics·Richard E Frye, Daniel A Rossignol
Jun 1, 2016·Frontiers in Neuroscience·Richard E FryeJames B Adams
Jun 25, 2016·The Journal of Comparative Neurology·Alain C BuretteRichard J Weinberg
Feb 13, 2018·Frontiers in Molecular Neuroscience·Charlotte Veyrat-DurebexHélène Blasco
Feb 23, 2020·The FEBS Journal·Carina MarangaSimão Teixeira da Rocha
Oct 27, 2018·Molecular Autism·Alain C BuretteRichard J Weinberg
Jun 14, 2020·International Journal of Molecular Sciences·Julia PanovHanoch Kaphzan
Mar 9, 2017·Frontiers in Molecular Neuroscience·Ning ChengSusan A Masino
May 28, 2020·Journal of Clinical Medicine·Lilach SimchiHanoch Kaphzan
Nov 20, 2016·American Journal of Medical Genetics. Part C, Seminars in Medical Genetics·Wen-Hann Tan, Lynne M Bird
Jun 7, 2017·Acta Neuropathologica·Merina VarghesePatrick R Hof
Jan 3, 2019·Journal of Molecular Neuroscience : MN·Mohammed H HassanAli Helmi Bakri
Jan 29, 2019·Frontiers in Molecular Neuroscience·Simon Jesse LopezJanine M LaSalle
Jun 23, 2016·Clinical Medicine Insights. Pediatrics·Richard E Frye, Daniel A Rossignol

Related Concepts

Ube3a protein, mouse
Founder Mice, Transgenic
Purkinje Cells
Synaptic Vesicles
Angelman Syndrome
Mice, Knockout
Ubiquitin-protein ligase

Related Feeds

Angelman Syndrome

Angelman syndrome is a neurogenetic imprinting disorder caused by loss of the maternally inherited UBE3A gene and is characterized by generalized epilepsy, limited expressive speech, sleep dysfunction, and movement disorders. Here is the latest research.